pyrimidine has been researched along with Innate Inflammatory Response in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XG; Guo, SX; He, SJ; Li, L; Liu, SW; Nandakumar, KS; Tang, XD; Wan, YH; Wu, WY; Wu, XY; Yao, XG; Zou, M | 1 |
| Duan, Y; Wang, Y | 1 |
| Elkamhawy, A; Hassan, AHE; Lee, HH; Lee, KT; Paik, S; Roh, EJ; Shin, JS; Sup Lee, Y | 1 |
| Burge, M; Clarke, S; Cordwell, C; Gibbs, P; Reece, W; Tebbutt, N | 1 |
| Ha, H; Neamati, N | 1 |
| FAVOUR, CB | 1 |
1 trial(s) available for pyrimidine and Innate Inflammatory Response
| Article | Year |
|---|---|
An Australian translational study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT].
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Inflammation; Leucovorin; Lymphocytes; Male; Neutrophils; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Prognosis; Proportional Hazards Models; Prospective Studies; Pyrimidines; Reproducibility of Results | 2013 |
5 other study(ies) available for pyrimidine and Innate Inflammatory Response
| Article | Year |
|---|---|
[1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation.
Topics: Animals; Antiviral Agents; Cell Proliferation; Cells, Cultured; Cricetinae; Dengue; Dengue Virus; Inflammation; Microbial Sensitivity Tests; Molecular Docking Simulation; Pyrimidines; Recombinant Proteins; RNA-Dependent RNA Polymerase; Surface Plasmon Resonance; Triazoles; Viral Nonstructural Proteins | 2020 |
P2Y14R for inflammation therapy: is it a promising target?
Topics: Anti-Inflammatory Agents; Benzofurans; Benzoic Acid; Biomarkers; Drug Evaluation, Preclinical; Humans; Inflammation; Naphthalenes; Purinergic P2 Receptor Antagonists; Pyrimidines; Receptors, Purinergic P2; Structure-Activity Relationship; Triazoles | 2021 |
EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Drug Discovery; ErbB Receptors; Humans; Inflammation; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; Nitric Oxide; Protein Kinase Inhibitors; Pyrimidines; RAW 264.7 Cells; Structure-Activity Relationship | 2019 |
Pyrimidine-based compounds modulate CXCR2-mediated signaling and receptor turnover.
Topics: Anti-Inflammatory Agents; Arrestins; beta-Arrestin 2; beta-Arrestins; Cell Line, Tumor; Cell Movement; Cyclic AMP; HL-60 Cells; Humans; Inflammation; Interleukin-8; Jurkat Cells; Pyrimidines; Receptors, Interleukin-8B; Signal Transduction; Tumor Microenvironment | 2014 |
Suppressive effect of systematic treatment with a pyrimidine derivative and with cortisone on local inflammation; suppression of inflammation. II.
Topics: Cortisone; Humans; Inflammation; Pyrimidines | 1958 |